Private equity firms are circling Bayer's (BAYGn.DE) 10 billion-euro ($12.7 billion) plastics business, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said on Wednesday.
MaterialScience
Breaking News
- Barclays Under Fire for Financing an Oil Company $4.4 Billion to Release 7.5 Million Tonnes of Carbon Emission
- Donald Trump's Allies Plan to Erode Fed's Independence by Giving Ex-POTUS Influence Over it if He Wins Election
- Maryland Athletic Director Uses AI-Generated Recording to Frame up Principal as Revenge Over Fraud Investigation Against Him
Bayer (BAYGn.DE) plans to sell its plastics business with an estimated value of about 8 billion euros ($10.3 billion) as part of a shift away from chemicals toward pharmaceuticals and crop science, a German newspaper reported, citing informed sources.
Subscribe to VCpost newsletter
Most Popular
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- JPMorgan CEO Warns of Economic Risks Amid Biden's 'Huge' Deficit Spending, Questions Likelihood of 'Soft Landing'
- Google's Parent Company Alphabet Approves First-Ever Dividend as Shares Skyrocket
- MSC Darwin Ship Targeted by Yemen's Houthis in Gulf of Aden
